Immediate Effects of Whole-Body Vibration on Neuromuscular Performance and Postural Control in Elderly
Launched by UNIVERSIDADE FEDERAL DO RIO GRANDE DO NORTE · Nov 22, 2017
Trial Information
Current as of July 21, 2025
Completed
Keywords
ClinConnect Summary
The research is a randomized controlled trial that will be developed at the Laboratório de Análise da Performance Muscular (LAPERN) of the Physiotherapy Department of the Federal University of Rio Grande do Norte (UFRN). The population of the present study will be formed by elderly individuals living in the city of Natal / RN, aged between 65 and 75 years, of both sexes, without distinction of race, education and marital status. The research sample will be of a non-probabilistic type, in which these will be allocated randomly into two distinct groups: placebo group (GP) and experimental gro...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Both genders;
- • Exhibiting ankle, hip and knee joint integrity of the non-dominant limb;
- • No history of muscle or joint injuries in the assessed limb in the last 6 months, or neurological, visual and/or non-corrected auditory impairments;
- • Do not have metallic implants in the lower limbs;
- • Do not have decompensated and / or untreated cardiovascular diseases;
- • Do not have advanced osteoporosis;
- • Do not have neurodegenerative diseases;
- • Do not have vestibular disorders;
- • Do not have uncorrected visual or hearing deficits.
- Exclusion Criteria:
- • Elderly classified as very active or active;
- • Report cardiac and / or respiratory discomfort, nausea, vertigo and pain during during the evaluations and exercise sessions;
- • Do not understand and do not correctly perform the commands offered in the assessment and / or intervention protocols;
About Universidade Federal Do Rio Grande Do Norte
The Universidade Federal do Rio Grande do Norte (UFRN) is a prestigious Brazilian institution dedicated to advancing education, research, and innovation in various fields, including health sciences. As a clinical trial sponsor, UFRN leverages its robust academic and research capabilities to contribute to the development of effective medical interventions and therapies. The university fosters collaborative partnerships with healthcare professionals, researchers, and industry stakeholders, ensuring that clinical trials conducted under its auspices adhere to the highest ethical standards and regulatory requirements. UFRN is committed to enhancing public health outcomes through rigorous scientific inquiry and the translation of research findings into clinical practice.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Natal, Rn, Brazil
Patients applied
Trial Officials
Daniel T Borges, MS
Principal Investigator
Universidade Federal do Rio Grande do Norte
Lidiane C Bulhões, Esp
Principal Investigator
Universidade Federal do Rio Grande do Norte
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials